DHJJ Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
DHJJ Financial Advisors's BMY Position: Q2 2026 in Review
DHJJ Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.36% in Q2 2026, buying an estimated $172 and bringing the position to 825 shares worth $47.5K. The position accounts for 0.01% of the portfolio, ranked #420.
DHJJ Financial Advisors first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $49.9K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- DHJJ Financial Advisors held 825 shares of Bristol-Myers Squibb worth $47.5K as of Q2 2026.
- DHJJ Financial Advisors bought 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
- Bristol-Myers Squibb made up 0.01% of DHJJ Financial Advisors's portfolio in Q2 2026, its #420 holding.
- DHJJ Financial Advisors first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
- DHJJ Financial Advisors's Bristol-Myers Squibb position peaked at $49.9K in Q1 2026.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.